The stock of Sun Pharma Advanced Research Company has gained 8.8 per cent with above average volume on Thursday, breaching a key resistance at ₹149. It has been in limelight over the past four trading sessions. The recent rally gives traders with a short-term perspective an opportunity to buy the stock at current levels of ₹154.7.

The stock can extend the uptrend and reach the price targets of ₹161 and ₹164 in the ensuing trading sessions. Buy the stock with a stop-loss at ₹151.